CD4 T cell-activating neoantigens enhance personalized cancer vaccine efficacy.
Huff AL, Longway G, Mitchell JT, Andaloori L, Davis-Marcisak E, Chen F, Lyman MR, Wang R, Mathew J, Barrett B, Rahman S, Leatherman J, Yarchoan M, Azad NS, Yegnasubramanian S, Kagohara LT, Fertig EJ, Jaffee EM, Armstrong TD, Zaidi N.
Huff AL, et al. Among authors: yegnasubramanian s.
JCI Insight. 2023 Dec 8;8(23):e174027. doi: 10.1172/jci.insight.174027.
JCI Insight. 2023.
PMID: 38063199
Free PMC article.